TAS-102 is an orally administered combination of a thymidine-based nucleic acid analogue, trifluridine, and a thymidine phosphorylase inhibitor, tipiracil hydrochloride.
TrustPilot
维克拉姆·D.
2 周前
Reema J.
1 个月前
拉维·S。
2 个月前
Farhan Q.